Longitudinal association between serum leptin concentration and glomerular filtration rate in humans

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Pedone, Claudio ^a   Roshanravan, Baback ^b   Scarlata, Simone ^a   Patel, Kushang V ^b   Ferrucci, Luigi ^c   Incalzi, Raffaele Antonelli ^a,d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d San Raffaele Cittadella della Carità Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; SEX DIFFERENCE; BLOOD; FOLLOW UP; KIDNEY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LEPTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; SEX FACTORS;

EID: 84923340825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117828     Document Type: Article

References (42)

1. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. (2008) Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52: 39-48. doi: 10.1053/j.ajkd.2008.03.003 PMID: 18440684.
2. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL (2003) Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 14: 479-487. doi: 10.1097/01.EDE.0000071413.55296.c4 PMID: 12843775.
3. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140: 167-174. PMID: 14757614.
4. Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16: 2134-2140. doi: 10.1681/ASN.2005010106 PMID: 15901764.
5. Hsu Cy, McCulloch CE, Iribarren C, Darbinian J, Go AS (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28. PMID: 16389251.
6. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. (2007) Prevalence of chronic kidney disease in the united states. JAMA 298: 2038-2047. doi: 10.1001/jama.298.17.2038 PMID: 17986697.
7. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D (2005) Obesity and prevalent and incident CKD: the hypertension detection and follow-up program. Am J Kidney Dis 46: 587-594. doi: 10.1053/j.ajkd.2005.06.007 PMID: 16183412.
8. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. (2005) Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46: 871-880. doi: 10.1053/j.ajkd.2005.08.015 PMID: 16253727.
9. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S (2004) Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876. doi: 10.1111/j.1523-1755.2004.00582.x PMID: 15086929.
10. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y (2003) The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14: 1480-1486. PMID: 12761248.
11. Griffin KA, Kramer H, Bidani AK (2008) Adverse renal consequences of obesity. Am J Physiol Renal Physiol 294: F685-696. doi: 10.1152/ajprenal.00324.2007 PMID: 18234955.
12. Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam M (2003) Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 12: 195-200. doi: 10.1097/01.mnh.0000058795. 51455.3f PMID: 12589181.
13. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G (2001) Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 14: 304S-309S. PMID: 11721888.
14. Kohler KA, McClellan WM, Ziemer DC, Kleinbaum DG, Boring JR (2000) Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes. Am J Kidney Dis 36: 903-913. doi: 10.1053/ajkd.2000.19080 PMID: 11054346.
15. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND study group (2002) Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 26 Suppl 4: S21-24. doi: 10.1038/sj.ijo.0802213 PMID: 12457295.
16. Klausen KP, Parving HH, Scharling H, Jensen JS (2009) Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 71: 40-45. doi: 10.1111/j.1365-2265.2008.03427.x PMID: 18803675.
17. Pinto-Sietsma SJ, Navis G, Janssen WMT, de Zeeuw D, Gans RO, de Jong PE, et al. (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41: 733-741. PMID: 12666059.
18. Praga M, Morales E (2010) Obesity-related renal damage: changing diet to avoid progression. Kidney Int 78: 633-635. doi: 10.1038/ki.2010.221 PMID: 20842147.
19. Mohan S, Tan J, Gorantla S, Ahmed L, Park CM (2012) Early improvement in albuminuria in non-diabetic patients after roux-en-y bariatric surgery. Obes Surg 22: 375-380. doi: 10.1007/s11695-011- 0437-7 PMID: 21590347.
20. Park HS, Park JY, Yu R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69: 29-35. doi: 10.1016/j.diabres.2004.11.007 PMID: 15955385.
21. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59: 1498-1509. doi: 10.1046/j.1523-1755.2001.0590041498.x PMID: 11260414.
22. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, et al. (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656. doi: 10.1172/JCI32691 PMID: 18431508.
23. Ma K, Cabrero A, Saha PK, Kojima H, Li L, et al. (2002) Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277: 34658-34661. doi: 10.1074/jbc.C200362200 PMID: 12151381.
24. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, et al. (2004) Adiponectin as a biomarker of the metabolic syndrome. Circ J 68: 975-981. PMID: 15502375.
25. Mathew AV, Okada S, Sharma K (2011) Obesity related kidney disease. Curr Diabetes Rev 7: 41-49. PMID: 21067508.
26. Wolf G, Ziyadeh FN (2006) Leptin and renal fibrosis. Contrib Nephrol 151: 175-183. doi: 10.1159/000095328 PMID: 16929141.
27. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, et al. (2000) Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48: 1618-25. PMID: 11129752.
28. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612. PMID: 19414839.
29. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DM, et al. (2008) Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52: 29-38. doi: 10.1053/j.ajkd.2008.02.363 PMID: 18511168.
30. Komura H, Nomura I, Kitamura K, Kuwasako K, Kato J (2013) Gender difference in relationship between body mass index and development of chronic kidney disease. BMC Res Notes 6: 463. doi: 10. 1186/1756-0500-6-463 PMID: 24225117.
31. Odagiri K, Mizuta I, Yamamoto M, Miyazaki Y, Watanabe H, Uehara A (2014) Waist to height ratio is an independent predictor for the incidence of chronic kidney disease. PLoS One 9: e88873. doi: 10.1371/journal.pone.0088873 PMID: 24533159.
32. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, et al. (2008) Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168: 2212-2218. doi: 10.1001/archinte.168.20.2212 PMID: 19001197.
33. Bemelmans MH, van Tits LJ, Buurman WA (1996) Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 16: 1-11. PMID: 8809470.
34. Van Snick J (1990) Interleukin-6: an overview. Annu Rev Immunol 8: 253-278. doi: 10.1146/annurev.iy.08.040190.001345 PMID: 2188664.
35. Ikezumi Y, Suzuki T, Karasawa T, Kawachi H, Nikolic-Paterson DJ, Uchiyama M (2008) Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases. Biochem Biophys Res Commun 376: 706-711. doi: 10.1016/j.bbrc.2008.09.049 PMID: 18809387.
36. Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, et al. (2005) Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312: 1170-1178. doi: 10.1124/jpet.104.078659 PMID: 15572648.
37. Munkhaugen J, Lydersen S, Wideroe TE, Hallan S (2009) Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 54: 638-646. doi: 10.1053/j.ajkd.2009.03.023 PMID: 19515474.
38. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S (2009) Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4: 1565-1574. doi: 10.2215/CJN.02250409 PMID: 19808241.
39. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR, et al. (1997) Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51: 1980-1985. PMID: 9186891.
40. Kastarinen H, Kesäniemi YA, Ukkola O (2009) Leptin and lipid metabolism in chronic kidney failure. Scand J Clin Lab Invest 69: 401-408. doi: 10.1080/00365510802706645 PMID: 19148833.
41. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE (2001) Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12: 1211-1217. PMID: 11373344.
42. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, et al. (2007) Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 18: 235-243. doi: 10.1681/ASN.2006040394 PMID: 17151331.